Clinical Study to Generate a Set of Data Characterising Clinical Events, Physiological Responses, and Innate and Adaptive Immune Responses Following a Single IM Immunisation With Boostrix® or Placebo in Healthy Adults
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2017
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Bordetella infections
- Focus Adverse reactions
- Acronyms BioVacSafe - Boostrix
- 06 Jun 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 06 Jun 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 13 Aug 2016 New source identified and integrated (European Clinical Trials Database; EudraCT2015-002879-14).